Ipsen has announced that its Iqirvo (elafibranor) tablets have been accepted by the Scottish Medicines Consortium (SMC) to treat adults with the rare cholestatic liver disease primary biliary ...

To maintain consistency and clinical relevance, rare pancreatic cancer subtypes with distinct biologic behaviors, such as squamous cell carcinoma, mucinous cystadenocarcinoma, solid ...

Eisai has filed for approval in Japan for tasurgratinib, its small-molecule fibroblast growth factor (FGF) receptor inhibitor, as a treatment for biliary tract cancers with FGFR2 gene fusion ...

Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the drug. Tasfygo (tasurgratinib succinate; formerly E7090), a small-molecule ...

The addition of multiparametric MRI to standard of care was cost-effective and enhanced diagnosis rates among patients with suspected metabolic dysfunction-associated liver disease, according to ...

Background: The presence of infective microorganisms in the bilio-pancreatic tract is believed to be important in both the onset and outcome of acute biliary pancreatitis. In this study ...

The Bismuth–Corlette classification system provides an anatomic description of the tumor location and longitudinal extension in the biliary tree (Figure 3). It is limited due to its failure to ...

Itchy skin, or pruritus, can be a symptom of liver disease. However, not everyone with liver disease experiences itching, and the specific causes of this itching are unknown. Treatment for itching ...

Cirrhosis of the liver is a severe condition, causing scarring and permanent damage to the liver. Life expectancy depends on the stage and type of liver cirrhosis, but it may vary between roughly ...

Topline data were announced from a phase 2/3 trial evaluating tovecimig in combination with paclitaxel in patients with unresectable advanced, metastatic or recurrent biliary tract cancers (BTC).